A 40-year study by Hospital for Special Surgery (HSS) researchers has found that active young adults who underwent total knee replacement were unlikely to require knee replacement revision in their lifetime, according to a new study shared today in a podium presentation at the American Academy of Orthopaedic Surgeons 2025 Annual Meeting.
Johnson & Johnson seeks approvals for paediatric HIV-1 therapy
The fixed-dose combination of PREZCOBIX/REZOLSTA is a collaborative effort between Janssen R&D Ireland and Gilead. Credit: Dmytro Zinkevych/ Shutterstock. Johnson & Johnson (J&J) has filed
June 5, 2024